Fidelity
Home > Boards > US Listed > Biotechs > ImmunoCellular Therapeutics, Ltd. (IMUC)

totally agree with that

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
biomanbaba Member Profile
 Grandfathered Member
Followed By 233
Posts 14,251
Boards Moderated 1
Alias Born 02/04/01
160x600 placeholder
Technical Notes on Top Gainers -- Research on Sequenom, ImmunoCellular Therapeutics, Intellicheck Mobilisa, and La Jolla Pharma "PR Newswire (US)" - 3/20/2014 8:33:00 AM
Annual Report (10-k) "Edgar (US Regulatory)" - 3/14/2014 3:39:08 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/13/2014 4:09:01 PM
ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2013 Financial Results "PR Newswire (US)" - 3/13/2014 4:00:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/12/2014 12:56:37 PM
ImmunoCellular Therapeutics Announces Change to Meeting Date for Annual Meeting of Stockholders "PR Newswire (US)" - 3/11/2014 4:15:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/10/2014 5:52:15 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/10/2014 5:51:50 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/10/2014 5:51:28 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/10/2014 5:50:53 PM
ImmunoCellular Therapeutics to Report Financial Results for the Fourth Quarter and Full Year 2013 on March 13, 2014 "PR Newswire (US)" - 3/4/2014 6:00:00 AM
ImmunoCellular Therapeutics to Present at ROTH Conference on March 11th "PR Newswire (US)" - 3/3/2014 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/25/2014 11:59:38 AM
ImmunoCellular Therapeutics Receives Orphan Drug Status for ICT-107 in Glioblastoma in the European Union "PR Newswire (US)" - 2/25/2014 6:00:00 AM
ImmunoCellular Therapeutics' Founder and Chief Scientific Officer, John Yu, MD, Presents at "Targeting Cancer Stem Cells" Sym... "PR Newswire (US)" - 2/14/2014 4:00:00 PM
ImmunoCellular Therapeutics to Present at the BIO CEO & Investor Conference on February 10, 2014 "PR Newswire (US)" - 2/3/2014 6:00:00 AM
ImmunoCellular Therapeutics Provides Update on 2014 Corporate Strategies and Milestones "PR Newswire (US)" - 1/13/2014 6:00:00 AM
ImmunoCellular Therapeutics Issues Shareholder Letter Providing Update on ICT-107 Program in Newly Diagnosed Glioblastoma "PR Newswire (US)" - 1/9/2014 4:38:00 PM
Tesla Gains After Safety Rating; Supernus Surges "Dow Jones News" - 12/24/2013 8:45:29 AM
ImmunoCellular Therapeutics Announces First Patient Receives Vaccine in Phase I Trial of Cancer Vaccine ICT-121 in Recurrent ... "Business Wire" - 12/23/2013 4:00:00 PM
Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of ImmunoCellular Therapeutics, Ltd. "Business Wire" - 12/12/2013 1:40:00 PM
ImmunoCellular Therapeutics Phase II Study Demonstrates That Glioblastoma Patients Live Longer Without Disease Progression Wh... "Business Wire" - 12/11/2013 4:00:00 PM
ImmunoCellular Therapeutics Expands Manufacturing Relationship with Progenitor Cell Therapy, LLC for Dendritic Cell Vaccines "Business Wire" - 12/3/2013 6:00:00 AM
D. E. Shaw & Co. LP 3Q 13F: Largest Eliminations "Dow Jones News" - 11/15/2013 8:53:19 AM
D. E. Shaw & Co. LP 3Q 13F: Largest Purchases "Dow Jones News" - 11/15/2013 8:53:15 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist